Want to see KOD full AI Analyst Report?
Kodiak Sciences (KOD) Stock Statistics & Valuation Metrics
Total Valuation
Kodiak Sciences has a market cap or net worth of $6.24B. The enterprise value is $2.47B.
- Market Cap
- $6.24B
- Enterprise Value
- $2.47B
Share Statistics
Kodiak Sciences has 62,849,457 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 62,849,457
- Owned by Insiders
- 38.72%
- Owned by Institutions
- 24.86%
Financial Efficiency
Kodiak Sciences’s return on equity (ROE) is -1.46 and return on invested capital (ROIC) is -73.69%.
- Return on Equity (ROE)
- -1.46
- Return on Assets (ROA)
- -0.65
- Return on Invested Capital (ROIC)
- -73.69%
- Return on Capital Employed (ROCE)
- -0.77
- Revenue Per Employee
- 0
- Profits Per Employee
- -1.63M
- Employee Count
- 141
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Kodiak Sciences is -23.70. Kodiak Sciences’s PEG ratio is 2.31.
- PE Ratio
- -23.70
- PS Ratio
- 0.00
- PB Ratio
- 101.79
- Price to FCF
- -39.03
- Price to Operating Cash Flow
- -39.24
- PEG Ratio
- 2.31
Income Statement
In the last 12 months, Kodiak Sciences had revenue of 0 and earned -229.97M in profits. Earnings per share was -4.32.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -234.39M
- Pretax Income
- -229.97M
- Net Income
- -229.97M
- EBITDA
- -203.65M
- Earnings Per Share (EPS)
- -4.32
Cash Flow
In the last 12 months, operating cash flow was -158.50M and capital expenditures -1.40M, giving a free cash flow of -159.90M billion.
- Operating Cash Flow
- -158.50M
- Free Cash Flow
- -159.90M
- Free Cash Flow per Share
- -2.55
Dividends & Yields
Kodiak Sciences pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -2.56%
- Earnings Yield
- -3.89%
Stock Price Statistics
- Beta
- 2.13
- 52-Week Price Change
- 487.57%
- 50-Day Moving Average
- 69.51
- 200-Day Moving Average
- 44.02
- Relative Strength Index (RSI)
- 61.76
- Average Volume (3m)
- 1.74M
Important Dates
Kodiak Sciences upcoming earnings date is Nov 12, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Aug 13, 2026
- Next Earnings Date
- Nov 12, 2026
- Ex-Dividend Date
- ―
Financial Position
Kodiak Sciences as a current ratio of 4.72, with Debt / Equity ratio of 101.14%
- Current Ratio
- 4.72
- Quick Ratio
- 4.72
- Debt to Market Cap
- 0.08
- Net Debt to EBITDA
- 0.25
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Kodiak Sciences has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Kodiak Sciences EV to EBITDA ratio is -29.04, with an EV/FCF ratio of -38.84.
- EV to Sales
- 0.00
- EV to EBITDA
- -29.04
- EV to Free Cash Flow
- -38.84
- EV to Operating Cash Flow
- -39.18
Balance Sheet
Kodiak Sciences has $125.90M in cash and marketable securities with $95.70M in debt, giving a net cash position of $30.20M billion.
- Cash & Marketable Securities
- $125.90M
- Total Debt
- $95.70M
- Net Cash
- $30.20M
- Net Cash Per Share
- $0.48
- Tangible Book Value Per Share
- $0.98
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Kodiak Sciences is $121.20, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- $121.20
- Price Target Upside
- 22.05% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 7
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- -10.60%
Scores
- Smart Score
- 8
- AI Score
- 52
